Inhibitors of Mutant IDH for the Treatment of Cancer

被引:2
作者
Abdel-Magid, Ahmed F. [1 ]
机构
[1] Therachem Res Medilab India Pvt Ltd, Jaipur, Rajasthan, India
关键词
D O I
10.1021/ml500400g
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:1184 / 1185
页数:2
相关论文
共 3 条
[1]   Differentiation therapy for IDH1/2 mutant malignancies [J].
Garrett-Bakelman, Francine E. ;
Melnick, Ari M. .
CELL RESEARCH, 2013, 23 (08) :975-977
[2]   Targeting IDH: the next big thing in AML [J].
Levis, Mark .
BLOOD, 2013, 122 (16) :2770-2771
[3]   Releasing the Block: Setting Differentiation Free with Mutant IDH Inhibitors [J].
Pirozzi, Christopher J. ;
Reitman, Zachary J. ;
Yan, Hai .
CANCER CELL, 2013, 23 (05) :570-572